Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly Goes All In On Solanezumab
Seeking Alpha
Saturday, July 13, 2013 - 12:07pm
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Eli Lilly's Management Hosts Update on Solanezumab Call (Transcript)
Yahoo/Seeking Alpha
Saturday, July 13, 2013 - 12:07pm
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Pet Diagnostics Grow Faster than Other Segments of the Animal Care Sector: How Does Human and Animal Care Relate and Differ? Which is a Better Ingredient for Your Portfolio?
Wall Street Transcript
Saturday, July 13, 2013 - 12:05pm
tags:
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Forbes
Saturday, July 13, 2013 - 12:04pm
tags:
JNJ
Large-Cap Pharmaceutical Stocks Continue to Show Attractive Yields: An Exclusive Interview with Expert Money Managers Reveals an Investment Philosophy Focused on Dividend-Paying Companies
Wall Street Transcript
Saturday, July 13, 2013 - 12:03pm
tags:
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, July 13, 2013 - 12:02pm
tags:
Merrimack Pharmaceuticals, GTx, Intuitive Surgical
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, July 13, 2013 - 11:46am
tags:
Prosensa, Alnylam, Web MD
Retail Sales Help Vivus
Seeking Alpha
Saturday, July 13, 2013 - 11:45am
tags:
Vivus
Merrimack Pharma Prices Stock and Convertible Note Issues
Motley Fool
Saturday, July 13, 2013 - 11:44am
tags:
Merrimack Pharmaceuticals
Faruqi & Faruqi, LLP Launches An Investigation Against Imprimis Pharmaceuticals, Inc. (IMMY) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Yahoo/BusinessWire
Saturday, July 13, 2013 - 11:43am
tags:
Imprimis Pharmaceuticals, lawsuits
Astellas Launches Xtandi in the UK
Yahoo/Zacks
Saturday, July 13, 2013 - 11:42am
tags:
Astellas, Xtandi, prostate cancer
Jazz Pharmaceuticals PLC: Today's Featured Health Care Laggard
The Street
Saturday, July 13, 2013 - 11:42am
tags:
Jazz
Questcor to Start Pilot Effort for Acthar
Yahoo/Zacks
Saturday, July 13, 2013 - 11:41am
tags:
Questcor Pharmaceuticals, H.P. Acthar Gel, sarcoidosis
Alexion rockets on Roche buyout speculation
Yahoo/AP
Saturday, July 13, 2013 - 11:39am
tags:
Alexion, Roche, M&A
Roche seeks financing for potential Alexion takeover: sources
Reuters
Friday, July 12, 2013 - 3:50pm
tags:
Roche, Alexion, M&A
Vivus weighs in with last-ditch effort to beat back First Manhattan contenders
Fierce Pharma
Friday, July 12, 2013 - 10:53am
tags:
Vivus
GSK, Theravance pull Relvar filing for COPD in Japan
Reuters
Friday, July 12, 2013 - 10:49am
tags:
relvar, COPD, GSK, Theravance, Japan
Lilly Aims Alzheimer’s Treatment at Early Stage Patients
Bloomberg
Friday, July 12, 2013 - 10:10am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
After $240 Million AstraZeneca Deal, How Big Will Moderna Get?
Forbes
Friday, July 12, 2013 - 10:07am
tags:
Moderna, AstraZeneca, MRNA
TrialCard Launches RxSaver, a Solution for Prescription Abandonment
CP Wire
Friday, July 12, 2013 - 9:28am
tags:
trialcard, RxSaver, prescription abandonent

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.